Resumen

GUAMAN LOZADA, María Dolores  y  GUAMAN LOZADA, Cody Francisco. Analysis of therapeutic drug and cardiovascular risk in Hypertensive and diabetic patients treated in outpatient units in primary care: Period May - November 2014. SCIENTIFICA [online]. 2015, vol.13, n.1, pp. 18-22. ISSN 1813-0054.

Introduction: The compensation values of glycemic and blood pressure as well as the ideal Drug Adherence is the primary objective in primary care units, as it has been demonstrated that adequate therapy and treatment, avoid preventable complications. Objetives: To evaluate the effectiveness of drug therapy administered in diabetic and hypertensive patients seen in primary care units.To identify the common cardiovascular risks. Material and methods: An observational design of the administered pharmaceutical and cardiovascular risk in diabetic and hypertensive patients treated in primary care units of the Ministry of Public Health, May-November period of 2014 was. There were selected 82 patients 66 with Hypertension arterial and 16 with type II Diabetes Mellitus, individuals were classified according to their age group and comorbidities. Intervention: The procedure to tensional mapping in hypertensive patients, rapid blood glucose tests in diabetic patients, anthropometric measurements, electrocardiograms, blood profiles were taken, the drug therapy administered drug therapy administered and procedures were evaluated over a period of six months. Results: The risk of cardiovascular and renal diseases is elevated in patients with comorbidities. Hypertension and DM II in patients older than 65 years presented higher incidence with a ratio of 1:6 men and women respectively. In ECG AV block with 35, 2% and ventricular growth with (48,7%) are the most frequent findings. The IECA (21, 2%), ARBs(31,1%), BB (14,3%) and CCBs(5,1%) are the most antihypertensive used drugs. In patients with Diabetes Mellitus II were used oral hypoglycemic (25,1%) and subcutaneous long-acting hypoglycemic (3,3%). Conclusion: Primary Care Units donot have variety of antihypertensive and hypoglycemic drugs for treating adequately with diseases such as diabetes and hypertension. The coronary disease and ventricular hypertrophy are the obvious effects of uncontrolled hypertension; diabetic nephropathy and the high risk of renal failure are proportional to the time of decompensating and inadequate management of patients.

Palabras llave : Atrioventricularblock (AVB); Angiotensin-converting enzyme inhibitors (IECA); Angiotensin II receptor blockers (ARBs); Beta-blockers (BB); Calcium channel blockers (CCBs).